Difference between revisions of "Team:Peking/Improve"

Line 344: Line 344:
 
                                 </div>
 
                                 </div>
 
                             </div>
 
                             </div>
−
           <div class="texttitle">Phase separation system.
+
           <div class="texttitle">Phase separation system
 
<a id="A"></a></div>  
 
<a id="A"></a></div>  
 
                             <hr style="border:2px dashed; height:2px" color="#666666">
 
                             <hr style="border:2px dashed; height:2px" color="#666666">
Line 352: Line 352:
 
                                     <p>What's more, we fused Frb-yEGFP with HOtag6 and fused FKBP-yEGFP with HOtag3. These two parts can form phase separation in the presence of rapamycin (Fig. 2). The original part <a href="http://parts.igem.org/Part:BBa_K209496">BBa_K209496</a> (Frb) and <a href="http://parts.igem.org/Part:BBa_K209496">BBa_K209023</a> (FKBP) have not this function. We uploaded 2 parts: <a href="http://parts.igem.org/Part:BBa_K2601010">BBa_K2601010</a> (Frb-yEGFP-HOTag6) and <a href="http://parts.igem.org/Part:BBa_K2601011">BBa_K2601011</a> (FKBP-yEGFP-HOTag3).<br/>
 
                                     <p>What's more, we fused Frb-yEGFP with HOtag6 and fused FKBP-yEGFP with HOtag3. These two parts can form phase separation in the presence of rapamycin (Fig. 2). The original part <a href="http://parts.igem.org/Part:BBa_K209496">BBa_K209496</a> (Frb) and <a href="http://parts.igem.org/Part:BBa_K209496">BBa_K209023</a> (FKBP) have not this function. We uploaded 2 parts: <a href="http://parts.igem.org/Part:BBa_K2601010">BBa_K2601010</a> (Frb-yEGFP-HOTag6) and <a href="http://parts.igem.org/Part:BBa_K2601011">BBa_K2601011</a> (FKBP-yEGFP-HOTag3).<br/>
  
−
Then, we drive the expression of Frb-yEGFP-HOTag6 with 3 promoters pUra3, pTEF1 and PDH3. As our <a href="https://2018.igem.org/Team:Peking/Model">Modeling</a> work predicts, the kinetics of a system depends on the concentration of the components and the interaction strength(Fig .3).
+
Then, we drive the expression of Frb-yEGFP-HOTag6 with 3 promoters pUra3, pTEF1 and PDH3. As our <a href="https://2018.igem.org/Team:Peking/Model">Modeling</a> work predicts, the kinetics of a system depends on the concentration of the components and the interaction strength(Fig .3). We successfully uploaded 5 parts form them: <a href="http://parts.igem.org/Part:BBa_K2601032">BBa_K2601032</a> (pTet07-Frb-yEGFP-HOTag6), <a href="http://parts.igem.org/Part:BBa_K2601033">BBa_K2601033</a> (pTEF1-Frb-yEGFP-HOTag6), <a href="http://parts.igem.org/Part:BBa_K2601034">BBa_K2601034</a> (PDH3-Frb-yEGFP-HOTag6), <a href="http://parts.igem.org/Part:BBa_K2601011">BBa_K2601011</a> (pTEF1-FKBP-yEGFP-HOTag3) and <a href="http://parts.igem.org/Part:BBa_K2601011">BBa_K2601011</a> (PDH3-yEGFP-HOTag3).
 +
 
 +
 
 +
 
 +
 
 +
 
 +
 
 +
<br/>
 +
 
 
<img src="https://static.igem.org/mediawiki/2018/d/d8/T--Peking--Demof5.png"><br/>
 
<img src="https://static.igem.org/mediawiki/2018/d/d8/T--Peking--Demof5.png"><br/>
 
<figcaption style="text-align:justify; text-justify:inter-ideograph;">
 
<figcaption style="text-align:justify; text-justify:inter-ideograph;">
Line 365: Line 373:
  
 
<br/>
 
<br/>
 +
 +
 
  </p>
 
  </p>
  

Revision as of 21:27, 16 October 2018

Improvement

In this section, you could see the Improvement.

Fuse with yEGFP

We fuse part BBa_K209496 (Frb) and BBa_K209023 (FKBP) with yEGFP, which make it visible in the yeast under fluorescent microscope. Then we got partBBa_K2601008(FKBP-yEGFP) and BBa_K2601007(Frb-yEGFP).

Afterward, we drive the expression of FKBP-yEGFP and Frb-yEGFP with 4 promoters pUra3, pTet07,pTEF1 and PDH3. The expression of these promoters were measure by flow cytometry(Fig. 1). We then got prats BBa_K2601021 (Tet07-Frb-yEGFP), K2601023 (PDH3-Frb-yEGFP), BBa_K2601025 (Tet07-FKBP-yEGFP), BBa_K2601026 (TEF1-FKBP-yEGFP), K2601027 (PDH3-FKBP-yEGFP).




Phase separation system

What's more, we fused Frb-yEGFP with HOtag6 and fused FKBP-yEGFP with HOtag3. These two parts can form phase separation in the presence of rapamycin (Fig. 2). The original part BBa_K209496 (Frb) and BBa_K209023 (FKBP) have not this function. We uploaded 2 parts: BBa_K2601010 (Frb-yEGFP-HOTag6) and BBa_K2601011 (FKBP-yEGFP-HOTag3).
Then, we drive the expression of Frb-yEGFP-HOTag6 with 3 promoters pUra3, pTEF1 and PDH3. As our Modeling work predicts, the kinetics of a system depends on the concentration of the components and the interaction strength(Fig .3). We successfully uploaded 5 parts form them: BBa_K2601032 (pTet07-Frb-yEGFP-HOTag6), BBa_K2601033 (pTEF1-Frb-yEGFP-HOTag6), BBa_K2601034 (PDH3-Frb-yEGFP-HOTag6), BBa_K2601011 (pTEF1-FKBP-yEGFP-HOTag3) and BBa_K2601011 (PDH3-yEGFP-HOTag3).

Figure. 3A The formation of SPOT can be described as a phase separation process of three components. Two important variable, the concentration of components and the interaction strength are marked in the figure.
Figure. 3B Flow Cytometry results of three promoters (Ura3, Tef2, and PDH3). The expression level of Ura3 is lowest while PDH3 is the strongest promoter.
Figure. 3C RapaSPOT of different promoter combinations after 10 μM rapamycin induction. Two axes stand for the expression level of components. After 3 hours, Only SPOT system with high level of Frb can be observed.
Figure. 3D Proportion of yeasts with granules after rapamycin induction. The rapamycin is from 1μM to 100 μM.